Anebulo Pharmaceuticals, Inc. (ANEB)
USD 1.23
(-6.11%)
USD 1.23
(-6.11%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -8.09 Million | -9.68 Million | -5.43 Million | -4.87 Million | -150.77 Thousand |
| Net Income | -8.2 Million | -11.73 Million | -6.82 Million | -30.25 Million | -174.63 Thousand |
| Depreciation & Amortization | 151.23 Thousand | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 758.88 Thousand | 884.72 Thousand | 480.66 Thousand | 199.94 Thousand | - |
| Change in working capital | -799.26 Thousand | 1.16 Million | 907.78 Thousand | -1.44 Million | 22.57 Thousand |
| Other non-cash items | 151.23 Thousand | 731 Thousand | 209.88 Thousand | 26.62 Million | 1286.00 |
| Investing Cash Flow | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - |
| Financing Cash Flow | -62.35 Thousand | 6.38 Million | - | 21.83 Million | 3.17 Million |
| Debt repayment | - | - | - | -201.28 Thousand | -200 Thousand |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | 8.2 Million | - |
| Common Stock Issuance | 654 Thousand | 6.64 Million | - | 22.85 Million | 2.97 Million |
| Other Financing Activities | -62.35 Thousand | -264.68 Thousand | - | -821.63 Thousand | 19.05 Million |
| Accounts receivables | - | - | - | 3500.00 | - |
| Accounts payables | -378.11 Thousand | 153.71 Thousand | 270.78 Thousand | 110.04 Thousand | - |
| Inventory | - | - | - | -3500.00 | - |
| Other working capital | -421.14 Thousand | -153.71 Thousand | 637 Thousand | -1.55 Million | 22.57 Thousand |
| Cash at beginning of period | 11.24 Million | 14.54 Million | 19.98 Million | 3.02 Million | - |
| Cash at end of period | 3.09 Million | 11.24 Million | 14.54 Million | 19.98 Million | 3.02 Million |
| Capital Expenditure | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -8.15 Million | -3.3 Million | -5.43 Million | 16.96 Million | 3.02 Million |
| Free Cash Flow | -8.09 Million | -9.68 Million | -5.43 Million | -4.87 Million | -150.77 Thousand |
| Breakdown | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.34 Million | -1.65 Million | -2.71 Million | -2.48 Million | -11.73 Million | -2.49 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 177.18 Thousand | 151.64 | 219.26 | 210.80 | 884.72 Thousand | 223.57 |
| Change in working capital | -939.85 Thousand | -55.17 Thousand | 652.56 Thousand | -456.79 Thousand | 1.16 Million | -577.23 Thousand |
| Other non-cash items | 59.69 Thousand | 145.09 Thousand | 31.83 Thousand | 179.39 Thousand | 731 Thousand | 259.92 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -62.35 Thousand | - | 6.38 Million | -68.15 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -62.35 Thousand | - | 6.64 Million | -68.15 Thousand |
| Other Financing Activities | - | - | -62.35 | - | -264.68 Thousand | -68.15 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -228.49 Thousand | 66.24 Thousand | -247.27 Thousand | 31.4 Thousand | 153.71 Thousand | -36.35 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -711.35 Thousand | -121.41 Thousand | 899.83 Thousand | -31.4 Thousand | -153.71 Thousand | -540.87 Thousand |
| Cash at beginning of period | 5.14 Million | 6.64 Million | 8.52 Million | 11.24 Million | 14.54 Million | 14.16 Million |
| Cash at end of period | 3.09 Million | 5.14 Million | 6.64 Million | 8.52 Million | 11.24 Million | 11.24 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -2.05 Million | -1.49 Million | -1.87 Million | -2.72 Million | -3.3 Million | -2.91 Million |
| Free Cash Flow | -2.05 Million | -1.49 Million | -1.81 Million | -2.72 Million | -9.68 Million | -2.84 Million |
ANX
GPHOF
002242
SX
MCLE
CAD